Furthermore, biomarkers can assist in therapeutic decision-making; for instance, D-dimer, fibrinogen, troponin, NT-proBNP, and CRP levels have been associated with CE, LVO, and LAA subtypes, thus aiding in treatment decisions (IVT, M.T) and secondary prevention strategies (long-term cardiac rhythm monitoring, anticoagulation, antiplatelet therapy). Here, NPPB is linked to cholesteryl ester measurement.